Does size influence your decision making for women with low or low-intermediate risk endometrial cancer after hysterectomy?

More recent Italian (Sozzi et al) and French data (Canlorbe et al) show associations of greater tumor size > 25-35mm with higher rates of local & regional recurrence. The ASTRO 2014 (Klopp et al) & ASCO 2015 (Meyer et al) guidelines don't appear to address tumor size which is understandable since classic prospective data such as GOG 99 and PORTEC-1 did not include tumor size as a risk factor. Also, Mayo Clinic (AlHilli et al) published a nomogram predicting for nodal mets including tumor size as a factor. Is there a similar nomogram in the works for predicting vagina cuff recurrence including tumor size as a factor? References: Sozzi et al: https://www.ncbi.nlm.nih.gov/pubmed/29489475 Canlorbe et al: https://www.ncbi.nlm.nih.gov/pubmed/25952272 Klopp et al: https://www.ncbi.nlm.nih.gov/pubmed/24766678 Meyer et al: https://www.ncbi.nlm.nih.gov/pubmed/26150442 AlHilli et al: https://www.ncbi.nlm.nih.gov/pubmed/23845691